- Discuss update with the new administration & executive orders impacting life sciences & drug development
- Discuss how these changes impact new and ongoing clinical trials both in Canada and with global trials
- Review how these changes offer opportunities for Canada’s Life Sciences sector
Speakers:
Vatche Bartekian, President & Founder, Vantage BioTrials Inc.
Dr. Mo Amin, Managing Director, Syneos Health, Board Advisor CRAC
Jaspreet Grewal, Co-Founder, CEO AxialBridge, Board Director of BioAlberta and CRAC
Kaushik Srinivasan, Managing Partner, Cerulean Health
Moderator: Sabrina Ramkellawan, President CRAC, Co-Founder, COO, AxialBridge